Orion Infusions (DHA:ORIONINFU) Net Change in Cash : BDT-3.4 Mil (TTM As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Orion Infusions Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Orion Infusions's Net Change in Cash for the three months ended in Dec. 2024 was BDT-7.8 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was BDT-3.4 Mil.

Orion Infusions Net Change in Cash Historical Data

The historical data trend for Orion Infusions's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Infusions Net Change in Cash Chart

Orion Infusions Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Net Change in Cash

Get a 7-Day Free Trial

3.71

-1.56

22.22

12.42

-22.65

Orion Infusions Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Change in Cash	Get a 7-Day Free Trial															-15.93	2.99	3.10	-1.65	-7.84

Orion Infusions Net Change in Cash Calculation

Orion Infusions's Net Change in Cash for the fiscal year that ended in Jun. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	57.453	+	-11.428	+	-68.674	+	0
	=	-22.6

Orion Infusions's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -8.439 + -2.495 + 3.09 + 0

= -7.8

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-3.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orion Infusions Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Orion Infusions's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Infusions Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Infusions Ltd (DHA:ORIONINFU) » Definitions » Net Change in Cash

Comparable Companies

DHA:ASIATICLAB DHA:TECHNODRUG DHA:CENTRALPHL DHA:ACMELAB ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506 BOM:500087 SZSE:000538 TSE:4507 UTHR NSE:TORNTPHARM

Traded in Other Exchanges

N/A

Address

153-154 Tejgaon I/A, Orion House, Dhaka, BGD, 1208

Website

https://www.orioninfusion.com

Orion Infusions Ltd is a pharmaceutical company. It produces various types of intravenous fluids, rehydration solutions, electrolyte solutions, antimicrobial products, and other pharmaceutical products in Bangladesh. The products of the company include Dextrolac, Dextropac, Dextrosal, Dianak, Electro dex, fructose, Hartman, Intralipid, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. In addition, the company is also involved in activities related to cosmetics and toiletries, infrastructure development, real estate and construction, power, agro products, hospitality, textiles and garments, and aviation management sectors. Geographically, it operates in Bangladesh.

Orion Infusions Headlines

No Headlines